Xlife Sciences AG (SWX: XLS)
Health Care · Life Sciences Tools & Services · CH
CHF9.80
-4.85% today · -51.0% 1Y
Xlife Sciences AG (SWX: XLS) operates in the Life Sciences Tools & Services industry within the Health Care sector. The company is valued at $68.02M.
Over the last twelve months the share price has lost 51.0%, trading between 9.34 and 26.80.
Tweenvest scores Xlife Sciences AG across four factors: quality 34/100, value 52/100, growth 0/100. Its strongest factor is value.
XLS price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $68.02M
- Revenue (TTM)
- $491.62K
- P/E
- —
- EPS
- -32.39
- Dividend yield
- —
- Beta (5Y)
- 0.50
- 52-week high
- CHF26.80
- 52-week low
- CHF9.34
- Avg volume (3M)
- —
- Shares outstanding
- 5.77M
- Employees
- —
- Next earnings
- —
Other Life Sciences Tools & Services companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Nanoform Finland OyjHLSE: NANOFH | $74.13M | €0.75 | -2.85% |
| HeXun Biosciences Co., Ltd.TPEX: 6986 | $72.23M | NT$44.30 | +0.68% |
| DreamCIS, Inc.KOSDAQ: A223250 | $71.00M | ₩3,880.00 | +0.13% |
| MindWalk Holdings Corp.NasdaqCM: HYFT | $70.43M | $1.55 | +3.68% |
| Champions Oncology, Inc.NasdaqCM: CSBR | $67.37M | $4.84 | -2.81% |
| Influx Healthtech LimitedNSEI: INFLUX | $64.67M | Rs270.35 | +5.61% |
| Immuno-Biological Laboratories Co., Ltd.TSE: 4570 | $63.05M | ¥1,072.00 | -6.38% |
| Fabtech Technologies LimitedNSEI: FABTECH | $61.19M | Rs133.22 | -6.19% |
Figures last refreshed Oct 11, 2026.